{
    "2021-10-28": [
        [
            {
                "time": "",
                "original_text": "基金持仓结构调整：「宁王」上位 多数基金Q3 选择「躺平」",
                "features": {
                    "keywords": [
                        "基金",
                        "持仓结构",
                        "宁王",
                        "躺平"
                    ],
                    "sentiment_score": -0.2,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "新能源",
                        "基金"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "国金证券维持天坛生物买入评级：业绩稳健增长，新批浆站不断突破",
                "features": {
                    "keywords": [
                        "国金证券",
                        "天坛生物",
                        "买入评级",
                        "业绩增长",
                        "新批浆站"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "国金证券：给予天坛生物买入评级",
                "features": {
                    "keywords": [
                        "国金证券",
                        "天坛生物",
                        "买入评级"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "【国联医药】天坛生物三季报点评：业绩符合预期，公司常规业务持续高增长",
                "features": {
                    "keywords": [
                        "国联医药",
                        "天坛生物",
                        "三季报",
                        "业绩预期",
                        "常规业务",
                        "高增长"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "国联证券：给予天坛生物增持评级",
                "features": {
                    "keywords": [
                        "国联证券",
                        "天坛生物",
                        "增持评级"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}